drugset / Trial / NCT04419636

Binding of Lu AG06466 in the Brain in Healthy Men

NCT04419636

Phase 1 Completed 16 enrolled H. Lundbeck A/S
RandomizedCrossoverOpen-labelTreatment

Summary

A study to learn how Lu AG06466 and one of its break down products binds in the brain after single and repeated dosing

Timeline

Start
2020-05-29
Primary completion
2021-02-09
Completion
2021-02-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown Oral

Indications

No indication recorded.